Sponsor Pipeline

Juntendo University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT05258279
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With…		 Trial completed
2026-07-30 NCT05258279
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With…		 date change Completion pushed: 2024-10 -> 2024-10-31
Active Trials by Phase
Phase 4
1
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07397650 Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With… Acute Heart Failure Recruiting
Phase 3
NCT05392764 Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients… Acute Heart Failure Recruiting
Disease Areas
Heart Failure (2)
Get alerts when Juntendo University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free